Live Feed

SHANGRAO, China, Oct. 17, 2026 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE:JKS), today unveiled Tiger Neo 5.0, an all-black residential solar module built on its all-new TAC technology. The first version to reach the market, an all-black 48-cell module, delivers a maximum power output of 510 W with a module efficiency of 25.52%. It was designed to redefine the upper limits of what a scenario-specific module can deliver in both appearance and efficiency for premium homes and other architecturally refined residences. The module showcases a deeper, more uniform and more refined black appearance than conventional back-contact (BC) modules. Semiconductor-gra

20 scientific presentations underscore the breadth of AbbVie's leadership in Inflammatory Bowel Disease (IBD) research programsLatest long-term and real-world data with SKYRIZI®(risankizumab) and RINVOQ® (upadacitinib) provide additional insight into clinical and endoscopic outcomes over approximately three years in moderately to severely active Crohn's disease and ulcerative colitisNew data evaluating endoscopic remission with investigational dual-targeting therapy ABBV-466 in patients with moderate-to-severe Crohn's disease will also be presentedNORTH CHICAGO, Ill., Oct. 17, 2026 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced the presentation of 20 new scientific abstracts from its IBD

VANCOUVER, BC, Oct. 16, 2026 /CNW/ -- Ballard Power Systems (NASDAQ:BLDP) (TSX:BLDP) will hold a conference call on Monday November 16th, 2026 at 8:00 a.m. Pacific Time (10:00 a.m. Eastern Time) to review third quarter 2026 operating results. The live call can be accessed by dialing +1-833-821-2814 (Canada/US toll free). Alternatively, a live webcast can be accessed through a link on Ballard's homepage (www.ballard.com), in the 'Latest News' section or by clicking here: Q3 Webcast. Following the call, a link to the webcast will be available in the 'Investor Hub' area of the 'Investors' section of Ballard's website (www.ballard.

4 - ASP Isotopes Inc. (0001921865) (Issuer)

4 - Firy Inc. (0001801661) (Issuer)

4 - Firy Inc. (0001801661) (Issuer)

SCHEDULE 13D/A - Hilltop Holdings Inc. (0001265131) (Subject)

ABU DHABI, United Arab Emirates, Oct. 16, 2026 (GLOBE NEWSWIRE) -- NIP Group Inc. ("NIP Group" or the "Company") (NASDAQ:NIPG), a leading digital entertainment company, today announced that the Company’s extraordinary general meeting of shareholders (the "EGM") was held in Hong Kong on October 16, 2026. During the EGM, the following proposed resolutions were duly passed: by a special resolution that, subject to the passing of Resolution 2, the Company’s authorized share capital be increased FROM US$200,000 divided into 2,000,000,000 shares comprising (i) 1,756,459,263 Class A ordinary shares of a par value of US$0.0001 each (the "Class A Ordinary Shares"), (ii) 148,331,658 Class B1 ordina

4 - Vertical Aerospace Ltd. (0001867102) (Issuer)

4 - WhiteFiber, Inc. (0002042022) (Issuer)

4 - WhiteFiber, Inc. (0002042022) (Issuer)

4 - WhiteFiber, Inc. (0002042022) (Issuer)

4 - Natera, Inc. (0001604821) (Issuer)

SCHEDULE 13D/A - ALX ONCOLOGY HOLDINGS INC (0001810182) (Subject)

4 - GrabAGun Digital Holdings Inc. (0002051380) (Issuer)

4 - GrabAGun Digital Holdings Inc. (0002051380) (Issuer)

Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, welcomes the decision of the Unified Patent Court ("UPC") finding that aligner systems incorporating Angelalign’s Torque Ridges feature infringe Align’s European Patent EP 2 237 738 B1, which relates to Align’s Power Ridge® technology.In August 2025, Align initiated patent infringement proceedings against several companies within the Angelalign Technology, Inc. corporate group ("Angel") (Hong Kong Stock Exchange: 6699.HK) in multiple jurisdictions, including before the UPC, which covers participating European Union member stat

4 - Moleculin Biotech, Inc. (0001659617) (Issuer)

4 - Moleculin Biotech, Inc. (0001659617) (Issuer)

4 - Moleculin Biotech, Inc. (0001659617) (Issuer)